ConductScience.org, home

Paper16632868

Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.

Tong M and 2 others. Carcinogenesis, 2006. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Papers, record 16632868. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16632868

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
PubMed
Journal
Carcinogenesis
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2007-12-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tong MMin
2Ding YYunfei
3Tai HHHsin-Hsiung

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Cyclooxygenase 2Major topic
Gene Expression Regulation, EnzymologicMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Hydroxyprostaglandin DehydrogenasesMajor topic
Lung NeoplasmsMajor topic
Adenoviridae
Cell Line, Tumor
Dose-Response Relationship, Drug
Humans
Immunoenzyme Techniques
RNA, Small Interfering

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HL-46296NHLBI NIH HHSUnited StatesR01HL046296PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
41971124A multi-omics prognostic model and functional validation of HPGD in clear cell renal cell carcinoma.Transl Androl Urol2026https://conductscience.org/library/papers/41971124PubMed
39973474Immunoregulatory mechanisms of the arachidonic acid pathway in cancer.FEBS Lett2025https://conductscience.org/library/papers/39973474PubMed
36312432Nicotinamide N-Methyltransferase Remodeled Cell Metabolism and Aggravated Proinflammatory Responses by Activating STAT3/IL1β/PGE2 Pathway.ACS Omega2022https://conductscience.org/library/papers/36312432PubMed
33596205Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/33596205PubMed
29959625Spilanthol Inhibits COX-2 and ICAM-1 Expression via Suppression of NF-κB and MAPK Signaling in Interleukin-1β-Stimulated Human Lung Epithelial Cells.Inflammation2018https://conductscience.org/library/papers/29959625PubMed
28029661Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.Oncotarget2017https://conductscience.org/library/papers/28029661PubMed
27075590HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells.Inflammation2016https://conductscience.org/library/papers/27075590PubMed
26819965Damage control: Harnessing prostaglandin E2 as a potential healing factor of tissue injuries.Genes Dis2015https://conductscience.org/library/papers/26819965PubMed
25433169Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.Prostaglandins Other Lipid Mediat2015https://conductscience.org/library/papers/25433169PubMed
25202373Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis.Oncol Lett2014https://conductscience.org/library/papers/25202373PubMed
24647712Postnatal regulation of 15-hydroxyprostaglandin dehydrogenase in the rat kidney.Am J Physiol Renal Physiol2014https://conductscience.org/library/papers/24647712PubMed
24514915Persisting eicosanoid pathways in rheumatic diseases.Nat Rev Rheumatol2014https://conductscience.org/library/papers/24514915PubMed
23687300
15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.
J Biol Chem2013https://conductscience.org/library/papers/23687300PubMed
2354217915-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.Oncogene2014https://conductscience.org/library/papers/23542179PubMed
22616846Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue.Arthritis Res Ther2012https://conductscience.org/library/papers/22616846PubMed
2241617715-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.World J Gastroenterol2012https://conductscience.org/library/papers/22416177PubMed
21738704Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line.PLoS One2011https://conductscience.org/library/papers/21738704PubMed
19820419Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.Pancreas2010https://conductscience.org/library/papers/19820419PubMed
19595472Restoration of leukotriene B(4)-12-hydroxydehydrogenase/15- oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo.Lung Cancer2010https://conductscience.org/library/papers/19595472PubMed
19383433Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.Neurosci Lett2009https://conductscience.org/library/papers/19383433PubMed

See all 24 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CBR1873PubTator's text mininghttps://conductscience.org/library/genes/873NCBI Gene
HPGD3248PubTator's text mininghttps://conductscience.org/library/genes/3248NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
MT-CO14512PubTator's text mininghttps://conductscience.org/library/genes/4512NCBI Gene
PTGS25743PubTator's text mininghttps://conductscience.org/library/genes/5743NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16632868

GET https://conductscience.org/api/papers/v1/16632868/cited_by?page=2